Localized unresectable pancreatic cancer.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2298636.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment results are presented for 40 patients with unresectable localized pancreatic cancer. The treatment protocol consisted of a split-course external radiation therapy to a dose of 50 Gy combined with intravenous 5-fluorouracil on the first 4 days of each course in a dose of 375 mg/m2/day. There was no treatment mortality and morbidity was moderate. Median survival was 9 months. The 3-year survival of six patients and the 5-year survival of three patients are considered significant enough to advise this combined treatment modality as a standard and to use it in comparison with newer treatment schemes in Phase III studies.
Medical subject headings
- Pancreatic Neoplasms